Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease
Eva de Lago, Paolo Urbani, José Antonio Ramos, Vincenzo Di Marzo, Javier Fernández-RuizVolume:
1050
Year:
2005
Language:
english
Pages:
7
DOI:
10.1016/j.brainres.2005.05.024
File:
PDF, 232 KB
english, 2005